Impact of race on diagnosis and management of cutaneous toxicities from immune checkpoint inhibitors

Published: 1 October 2020| Version 1 | DOI: 10.17632/m689r3v4r3.1
Contributors:
Leah Thompson,
Catherina Pan,
Michael Chang,
Nira Krasnow,
Steven Chen,
Amy Blum

Description

Study flow diagram showing process of selecting patients receiving immune checkpoint inhibitors with confirmed cirAE diagnoses

Files

Categories

Flow Chart

License